EASE: Engage Assess Secrete
The Mayo Clinic, focusing on the Living Pharmacy track, which will use engineered cells stored in a bioelectronic device to treat Inflammatory Bowel Disease (IBD). Their Engage Assess Secrete (EASE) device will release antibodies to address inflammation and alleviate the current treatment burden of drugs administered every 2-8 weeks.